» Articles » PMID: 39370942

Exploring the Dynamics and Interactions of the N-myc Transactivation Domain Through Solution Nuclear Magnetic Resonance Spectroscopy

Overview
Journal Biochem J
Specialty Biochemistry
Date 2024 Oct 7
PMID 39370942
Authors
Affiliations
Soon will be listed here.
Abstract

Myc proteins are transcription factors crucial for cell proliferation. They have a C-terminal domain that mediates Max and DNA binding, and an N-terminal disordered region culminating in the transactivation domain (TAD). The TAD participates in many protein-protein interactions, notably with kinases that promote stability (Aurora-A) or degradation (ERK1, GSK3) via the ubiquitin-proteasome system. We probed the structure, dynamics and interactions of N-myc TAD using nuclear magnetic resonance (NMR) spectroscopy following its complete backbone assignment. Chemical shift analysis revealed that N-myc has two regions with clear helical propensity: Trp77-Glu86 and Ala122-Glu132. These regions also have more restricted ps-ns motions than the rest of the TAD, and, along with the phosphodegron, have comparatively high transverse (R2) 15N relaxation rates, indicative of slower timescale dynamics and/or chemical exchange. Collectively these features suggest differential propensities for structure and interaction, either internal or with binding partners, across the TAD. Solution studies on the interaction between N-myc and Aurora-A revealed a previously uncharacterised binding site. The specificity and kinetics of sequential phosphorylation of N-myc by ERK1 and GSK3 were characterised using NMR and resulted in no significant structural changes outside the phosphodegron. When the phosphodegron was doubly phosphorylated, N-myc formed a robust interaction with the Fbxw7-Skp1 complex, but mapping the interaction by NMR suggests a more extensive interface. Our study provides foundational insights into N-myc TAD dynamics and a backbone assignment that will underpin future work on the structure, dynamics, interactions and regulatory post-translational modifications of this key oncoprotein.

References
1.
Takeuchi K, Heffron G, Sun Z, Frueh D, Wagner G . Nitrogen-detected CAN and CON experiments as alternative experiments for main chain NMR resonance assignments. J Biomol NMR. 2010; 47(4):271-82. PMC: 2946331. DOI: 10.1007/s10858-010-9430-z. View

2.
Kovermann M, Rogne P, Wolf-Watz M . Protein dynamics and function from solution state NMR spectroscopy. Q Rev Biophys. 2016; 49:e6. DOI: 10.1017/S0033583516000019. View

3.
McMahon S, Van Buskirk H, Dugan K, Copeland T, Cole M . The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell. 1998; 94(3):363-74. DOI: 10.1016/s0092-8674(00)81479-8. View

4.
Flinn E, Busch C, Wright A . myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol Cell Biol. 1998; 18(10):5961-9. PMC: 109182. DOI: 10.1128/MCB.18.10.5961. View

5.
Wang L, Teshiba R, Ikegaki N, Tang X, Naranjo A, London W . Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study. Br J Cancer. 2015; 113(1):57-63. PMC: 4647535. DOI: 10.1038/bjc.2015.188. View